RESEARCH PAPER
Quality of life and occurrence of depression under chemotherapy in patients suffering from lung carcinoma
| 1 | Faculty of Nursing and Health Sciences, Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University of Lublin, Poland |
| 2 | St John’s Oncology Centre in Lublin, Poland |
| 3 | Faculty of Nursing and Health Sciences, Department of Applied Psychology, Medical University of Lublin, Poland |
| 4 | Faculty of Physical Education and Health Promotion, Department of Health Promotion, Szczecin University, Poland |
| 5 | Department of Health Education; Institute of Rural Health, Lublin, Poland |
| 6 | Head of Internal Diseases Ward, Provincial Hospital, Szczecin, Poland |
Ann Agric Environ Med. 2014;21(4):783–789
KEYWORDS
ABSTRACT
Introduction and objective:
In Poland, lung carcinoma is the most frequent malignant neoplasm in men and the third most frequent in women. The neoplastic disease causes enormous psychic stress and may lead to depressive reactions. The purpose of this research was to assess the quality of life and the occurrence of depression in patients suffering from lung neoplasms and undergoing chemotherapy.
Material and Methods:
The research covered 102 patients (test group TG) with lung carcinoma and undergoing chemotherapy. In the research, standardised questionnaires: EORTC‑QLQ‑C30, Beck Depression Inventory and a matrix developed by the researcher were applied. The control group (CG) consisted of 60 healthy people who were examined by the Beck Depression Inventory.
Results:
A highly statistically significant dependency was found (p<0.01) between the general quality of life and the occurrence of depression. 51.5% of those examined with a very low level of general quality of life had the symptoms of severe depression. Those examined who had a very high level of general quality of life did not have features of severe depression. A statistically significant dependency (p<0.01) was ascertained between the occurrence of depression and the health condition of those examined.
Conclusions:
Depression symptoms occur more frequently and with greater intensity in patients suffering from lung neoplasm, compared to the group of healthy people (p<0.01). A statistically significant connection between marital status, place of residence, and assessment of quality of life was found out (p<0.05).
In Poland, lung carcinoma is the most frequent malignant neoplasm in men and the third most frequent in women. The neoplastic disease causes enormous psychic stress and may lead to depressive reactions. The purpose of this research was to assess the quality of life and the occurrence of depression in patients suffering from lung neoplasms and undergoing chemotherapy.
Material and Methods:
The research covered 102 patients (test group TG) with lung carcinoma and undergoing chemotherapy. In the research, standardised questionnaires: EORTC‑QLQ‑C30, Beck Depression Inventory and a matrix developed by the researcher were applied. The control group (CG) consisted of 60 healthy people who were examined by the Beck Depression Inventory.
Results:
A highly statistically significant dependency was found (p<0.01) between the general quality of life and the occurrence of depression. 51.5% of those examined with a very low level of general quality of life had the symptoms of severe depression. Those examined who had a very high level of general quality of life did not have features of severe depression. A statistically significant dependency (p<0.01) was ascertained between the occurrence of depression and the health condition of those examined.
Conclusions:
Depression symptoms occur more frequently and with greater intensity in patients suffering from lung neoplasm, compared to the group of healthy people (p<0.01). A statistically significant connection between marital status, place of residence, and assessment of quality of life was found out (p<0.05).
REFERENCES (25)
1.
Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Syst Rev. 2013; 2: 10. doi: 10.1186/2046-4053-2-10.
2.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. Cancer J Clin. 2013; 63(1): 11–30.
4.
Jassem E, Szymanowska A, Siemińska A, Jassem J. Palenie tytoniu a rak płuca. Pneumonologia Alergologia Polska 2009; 77(5): 469–473.
5.
Rybojad P, Dłuski D, Rybojad B, Kędra M, Sawicki M, Skoczylas P, Tabarkiewicz J. Urban vs. rural patients. Differenc in stage and overall survival among patients treated surgically for lung cancer. Ann Agric Environ Med. 2013; 20(1): 101–105.
6.
Sawicki M, Szczyrek M, Krawczyk P, Rybojad P, Jabłonka A, Milanowski J. Reasons for delay in diagnosis and treatment of lung cancer among patients in Lublin Voivodeship who were consulted in Thoracic Surgery Department. Ann Agric Environ Med. 2013; 20(1): 72–76.
7.
Yun YH, Shon EJ, Yang AJ, Kim SH, Kim YA, Chang YJ, Lee J, Kim MS, Lee HS, Zo JI, Kim J, Choi YS, Shim YM. Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer. Ann Oncol. 2013; 24(6): 1552–1559. doi: 10.1093/annonc/mdt032. Epub 2013 Mar 6.
8.
Mess E, Falewicz M, Lisowska A, et al. Występowanie depresji u pacjentów z nowotworem płuc. Onkol Pol. 2006; 9(4): 154–157 (in Polish).
9.
www.eortc.be/home/qol/files/C30/QLQ-C30%20Polish%20n.pdf/ (in Polish) (access: 24.06.2010).
11.
Damm K, Roeske N, Jacob C. Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Econ Rev. 2013; 3(1): 15. doi: 10.1186/2191-1991-3-15.
12.
De Walden-Gałuszko K, Majkowicz M. Ocena jakości opieki paliatywnej w teorii i praktyce. Wydawnictwo Uniwersytetu Gdańskiego, Gdańsk 2000.p.32 (in Polish).
13.
www.eortc.be/home/qol/files/SCManualQLQ-C30.pdf/ (in Polish) (access: 24.06.2010).
14.
Nowicki A, Krzymińska J, Kowalewski J. Ocena jakości życia chorych leczonych operacyjnie z powodu raka płuca. Współczesna Onkologia 2006; 10(9): 468–474 (in Polish).
15.
Zielińska-Więczkowska H, Betłakowski J. Jakość życia pacjentów z chorobą nowotworowa poddanych chemioterapii. Współczesna Onkologia 2010; 14(13): 276–280 (in Polish).
16.
Larsson M, Ljung L, Johansson BB. Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data. Eur J Cancer Care (Engl). 2012; 21(5): 642–649. doi: 10.1111/j.1365-2354.2012.01346.x.
17.
Arrieta O, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, Alvarado S, Corona-Cruz JF, Oñate-Ocaña LF. Association of Depression and Anxiety on Quality of Life, Treatment Adherence, and Prognosis in Patients with Advanced Non-small Cell Lung Cancer. Ann Surg Oncol. 2013; 20(6): 1941–1948. doi: 10.1245/s10434-012-2793-5.
18.
Szymczak J. Poczucie koherencji a depresja u chorych zakwalifikowanych do operacji z powodu nowotworu płuca i u osób zdrowych. Psychoonkologia 2001; 8: 35–46 (in Polish).
19.
Zielińska-Więczkowska H, Betłakowski J. Analiza nasilenia stanów depresyjnych u pacjentów z chorobą nowotworową przed i w trakcie chemioterapii. Wiadomości Lekarskie. 2010; LXIII(2): 46–53 (in Polish).
20.
Mess E, Szmyd K, Wójcik D, Kempińska E. Jakość życia pacjentów w terminalnej fazie choroby nowotworowej. Onkologia Polska. 2005; 8(3): 158–161 (in Polish).
21.
Nowicki A, Rządkowska B. Depresja i lęk u chorych z nowotworami złośliwymi. Współczesna Onkologia. 2005; 9(9): 396–403 (in Polish).
22.
Fox S, Lyon D. Symptom clusters and quality of life in survivors of lung cancer. Oncology Nursing Forum. 2006; 33(5): 931–936.
23.
Uchitomi Y, Mikami I, Nagai K, et al. Depression and Psychological Distress in Patients During the Year After Curative Resection of Non-Small-Cell Lung Cancer. Journal of Clinical Oncology. 2003; 21(1): 69–77.
24.
Sharpe M, Strong V, Allen K, et al. Major depression in outpatients attending a regional cancer center; screening and unmet treatment needs. Br J Cancer. 2004; 80: 1770–1780.
25.
Shimizu K, Nakaya N, Saito-Nakaya K, et al. Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project. Annals of Oncology. 2012; 23(8): 1973–1979.
RELATED ARTICLE
Improvement of visual identification of the journal - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher Education allocated to the activities of disseminating science.
Generation of the DOI (Digital Object Identifier) - task financed under the agreement No. 618/P-DUN/2019 by the Minister of Science and Higher
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.